Similarly to the first Sort1-/- model described (Rabinowich et al., 2015; Hagita et al., 2018), NT-deficient mice are resistant to DIO, hepatic steatosis and insulin resistance (Li et al., 2016). Here, SORT1 is linked to Insulin resistance.